TrialThe journal of prevention of Alzheimer's disease2025

The effect of modified donanemab titration on amyloid-related imaging abnormalities with edema/effusions and amyloid reduction: 18-month results from TRAILBLAZER-ALZ 6.

Hong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.